Eldad Matityahu
Founding Managing Director
About
Eldad Matityahu is a proven technology innovator, serial entrepreneur and Investor. Matityahu is currently at EC Partners, an investment company with a focus on leading edge technology. With a passion for and proven track record in cultivating successful global businesses, Matityahu is on the hunt for next-generation cutting edge information technologies. Matityahu founded and built Net Optics into the leading provider of network access and visibility solutions worldwide. He led the company as its Chief Executive Officer from 1996-2001 and served as Chairman of the Board until its acquisition by Ixia in December, 2013. He is now turning his passion and vision toward investing in early stage high-tech companies. As a founder of the network visibility space, Eldad is a shaper of markets, strategic business thinker, vision leader, recognized customer advocate and expert on network monitoring and performance management. Known for early recognition of market opportunities, Eldad led all aspects of product design and engineering for Net Optics and pioneered innovations enabling enterprises to access and secure every layer of their physical and virtual data centers. Having driven 60+ successive profitable quarters, Eldad is recognized as a business driver and high-impact problem solver. Engineering innovation and high-growth entrepreneurial leadership distinguish Eldad’s impact on network visibility, network packet brokering, and performance monitoring. Eldad is recognized as one of IT’s most committed advocates for customer collaboration and transparency. His white glove “Customer First!” approach is a hallmark of Net Optics. Results show in Net Optics' market leadership and high visibility in media and analyst conversations. Net Optics was named to Inc. Magazine’s Top 500/5000 and Silicon Valley’s Fastest Growing Private Company lists, and Red Herring's Top 100 North America and Global Awards, recognizing the world's most innovative tech companies."
United States
Santa Clara
Computer & Network Security
Network Security, IT Operations, serial entrepreneur, founder, CEO, network operations, Globalization, market strategy, Customer Service, Engineering, Product Design, network innovation, Network Monitoring Tools, Network Performance Management, Application Performance Management, Entrepreneurship, Networking, Marketing Strategy, Leadership, Cloud Computing
Experience

Founding Managing Director
EC Partners
Palo Alto
In 2014, we started EC Partners with a vision of helping companies realize their full growth potential. As founder and leader of a fast-growing company, I learned first hand about the value of hard work and innovation, striving against odds and following a dream. We view ourselves as a growth investor that provides strategic and operational guidance to help proven, existing management teams reach their companies security and telecommunications startups realize their full growth potential.

Member of the Board Lead Investor
Epix Orthopaedics
Palo Alto
Eldad Matityahu is a board member and a lead investor in a life changing technology startup Epix Orthopaedics. www.epixortho.com

Private Investor, leading round B
Retrotope
Palo Alto, CA
Retrotrope is changing aging as we know it, so that people do not have to suffer the ravages of many degenerative diseases. Retrotope is a pharmaceutical company startup that is leading the advance of a revolutionary new unified theory of aging and degeneration that can result in dramatically new approaches to therapy. This theory is based on three groundbreaking discoveries: 1) Many disparate degenerative diseases share a common weakness. T2) hat weakness is one type of chemical bond that makes membrane fats susceptible to oxidation damage and loss of function. 3) By strengthening that bond, we are able to prevent and even reverse disease damage. Based on this observation, Retrotope is creating a new category of drugs composed of proprietary, compounds that treat degenerative diseases and improve life as we age. Its first drug treats a rare neurodegenerative disease, Friederich’s Ataxia, as a rapid proof of human concept, and preclinical data support use of the drug category in major diseases like Alzheimer’s, Parkinson’s, and retinopathies. http://www.retrotope.com
Eldad Matityahu's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.


